An Important Role of CDK Inhibitor p18INK4c in Modulating Antigen Receptor-Mediated T Cell Proliferation
Open Access
- 15 September 2001
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 167 (6) , 3285-3292
- https://doi.org/10.4049/jimmunol.167.6.3285
Abstract
The inhibitors of cyclin-dependent kinase (CDK) 4 (INK4) bind CDK4/6 to prevent their association with D-cyclins and G1 cell cycle initiation and progression. We report here that among the seven CDK inhibitors, p18INK4c played an important role in modulating TCR-mediated T cell proliferation. Loss of p18INK4c in T cells led to hyperproliferation in response to CD3 stimulation. p18INK4c-null mice developed lymphoproliferative disorder and T cell lymphomas. Expression of IL-2, IL-2R-α, and the major G1 cell cycle regulatory proteins was not altered in p18-null T cells. Both FK506 and rapamycin efficiently inhibited proliferation of p18-null T cells. In activated T cells, p18INK4c remained constant, and preferentially associated with and inhibited CDK6 but not CDK4. We propose that p18INK4c sets an inhibitory threshold in T cells and one function of CD28 costimulation is to counteract the p18INK4c inhibitory activity on CDK6-cyclin D complexes. The p18INK4c protein may provide a novel target to modulate T cell immunity.Keywords
This publication has 69 references indexed in Scilit:
- The mechanism of action of cyclosporin A and FK506Published by Elsevier ,2003
- Limited overlapping roles of P15INK4b and P18INK4c cell cycle inhibitors in proliferation and tumorigenesisThe EMBO Journal, 2000
- Generic Signals and Specific OutcomesCell, 1999
- The Interleukin-4 Receptor Activates STAT5 by a Mechanism That Relies upon Common γ-ChainJournal of Biological Chemistry, 1998
- Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and agingOncogene, 1997
- Cancer Cell CyclesScience, 1996
- Molecular analysis of a family of cyclin-dependent kinase inhibitor genes (p15/MTS2/INK4b and p18INK4c) in non-small cell lung cancers: Kawamata N, Miller CW, Koeffler HP. Cedars-Sinai Medical Institute, UCLA School of Medicine, 8700 Beverley Blvd, Los Angeles, CA 90048 Mol Carcinog 1995;14:263–268Lung Cancer, 1996
- Biochemical Characterization of p16 - and p18-containing Complexes in Human Cell LinesPublished by Elsevier ,1996
- CD28/B7 SYSTEM OF T CELL COSTIMULATIONAnnual Review of Immunology, 1996
- Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.Proceedings of the National Academy of Sciences, 1990